These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 30626681)

  • 21. Pathogenesis of arenavirus hemorrhagic fevers.
    Moraz ML; Kunz S
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):49-59. PubMed ID: 21171877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.
    Oppliger J; Torriani G; Herrador A; Kunz S
    J Virol; 2016 Jul; 90(14):6412-6429. PubMed ID: 27147735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arenavirus extinction through lethal mutagenesis.
    de la Torre JC
    Virus Res; 2005 Feb; 107(2):207-14. PubMed ID: 15649566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor.
    Chou YY; Cuevas C; Carocci M; Stubbs SH; Ma M; Cureton DK; Chao L; Evesson F; He K; Yang PL; Whelan SP; Ross SR; Kirchhausen T; Gaudin R
    J Virol; 2016 May; 90(9):4494-4510. PubMed ID: 26912630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
    Zhang Z; Takenaga T; Fehling SK; Igarashi M; Hirokawa T; Muramoto Y; Yamauchi K; Onishi C; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    J Virol; 2024 Jul; 98(7):e0071424. PubMed ID: 38809021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arenavirus Quasispecies and Their Biological Implications.
    Grande-Pérez A; Martin V; Moreno H; de la Torre JC
    Curr Top Microbiol Immunol; 2016; 392():231-76. PubMed ID: 26472215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-induced activation of arenavirus membrane fusion is antagonized by small-molecule inhibitors.
    York J; Dai D; Amberg SM; Nunberg JH
    J Virol; 2008 Nov; 82(21):10932-9. PubMed ID: 18768973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mining a Kröhnke Pyridine Library for Anti-Arenavirus Activity.
    Miranda PO; Cubitt B; Jacob NT; Janda KD; de la Torre JC
    ACS Infect Dis; 2018 May; 4(5):815-824. PubMed ID: 29405696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axl Can Serve as Entry Factor for Lassa Virus Depending on the Functional Glycosylation of Dystroglycan.
    Fedeli C; Torriani G; Galan-Navarro C; Moraz ML; Moreno H; Gerold G; Kunz S
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Arenaviruses by Combinations of Orally Available Approved Drugs.
    Herring S; Oda JM; Wagoner J; Kirchmeier D; O'Connor A; Nelson EA; Huang Q; Liang Y; DeWald LE; Johansen LM; Glass PJ; Olinger GG; Ianevski A; Aittokallio T; Paine MF; Fink SL; White JM; Polyak SJ
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.
    Tani H; Iha K; Shimojima M; Fukushi S; Taniguchi S; Yoshikawa T; Kawaoka Y; Nakasone N; Ninomiya H; Saijo M; Morikawa S
    J Virol; 2014 Jul; 88(13):7317-30. PubMed ID: 24741091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.
    Rojek JM; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
    J Virol; 2008 Aug; 82(15):7677-87. PubMed ID: 18508885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.
    Takenaga T; Zhang Z; Muramoto Y; Fehling SK; Hirabayashi A; Takamatsu Y; Kajikawa J; Miyamoto S; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.
    Radoshitzky SR; Kuhn JH; de Kok-Mercado F; Jahrling PB; Bavari S
    Expert Opin Drug Discov; 2012 Jul; 7(7):613-32. PubMed ID: 22607481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myristoylation of the Arenavirus Envelope Glycoprotein Stable Signal Peptide Is Critical for Membrane Fusion but Dispensable for Virion Morphogenesis.
    York J; Nunberg JH
    J Virol; 2016 Sep; 90(18):8341-50. PubMed ID: 27412594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
    Bolken TC; Laquerre S; Zhang Y; Bailey TR; Pevear DC; Kickner SS; Sperzel LE; Jones KF; Warren TK; Amanda Lund S; Kirkwood-Watts DL; King DS; Shurtleff AC; Guttieri MC; Deng Y; Bleam M; Hruby DE
    Antiviral Res; 2006 Feb; 69(2):86-97. PubMed ID: 16343651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamp1 Increases the Efficiency of Lassa Virus Infection by Promoting Fusion in Less Acidic Endosomal Compartments.
    Hulseberg CE; Fénéant L; Szymańska KM; White JM
    mBio; 2018 Jan; 9(1):. PubMed ID: 29295909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.
    Rathbun JY; Droniou ME; Damoiseaux R; Haworth KG; Henley JE; Exline CM; Choe H; Cannon PM
    J Virol; 2015 Aug; 89(16):8428-43. PubMed ID: 26041296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell entry by human pathogenic arenaviruses.
    Rojek JM; Kunz S
    Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel drug discovery approaches for treating arenavirus infections.
    Pasquato A; Kunz S
    Expert Opin Drug Discov; 2016; 11(4):383-93. PubMed ID: 26882218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.